KY
Krishna Yeshwant
OtherActiveManaging Partner at GV
94
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Krishna Yeshwant.
Investment Thesis & Strategy
GV invests in various stages of companies across biotech, consumer health, security, and social networks, seeking to partner with innovative and disruptive companies.
Portfolio Companies
Selected investments from their portfolio of 94 companies
D
Doppler
Other · , 0
T
Taysha Gene Therapies
Other · , 0
N
Nothing
Other · , 0
C
Clear Labs
Other · , 0
G
Good Eggs
Other · , 0
K
Kronos Bio
Other · , 0
S
SQZ Biotech
Other · , 0
M
Monte Rosa Therapeutics
Other · , 0
R
Relay Therapeutics
Other · , 0
S
Scandit
Other · , 0
I
Insitro
Other · , 0
H
Headway
Other · , 0
Frequently Asked Questions
Krishna Yeshwant focuses on Series B stage investments.